HIMS vs TDOC

Hims & Hers is aggressively executing on its strategy to pivot into high-growth chronic care, particularly weight loss, and expand internationally, as evidenced by the completed Eucalyptus acquisition and strong international revenue growth (+969% YoY in Q1 2026). The reaffirmed 2030 targets of $6.5 billion revenue underscore a compelling long-term vision and market opportunity. However, this grow...

Teladoc Health operates in a vast virtual care market with a compelling whole-person health vision, but recent Q1 2026 results show significant headwinds. Revenue declined 2.5% YoY, and free cash flow was a notable -$26.3 million outflow, indicating persistent cash burn and challenging top-line execution. While operating margins improved, overall profitability remains elusive. Competitive advantag...